Home » Topics » BioWorld Science

BioWorld Science
RSS

Dimethaid highlights Pennsaid progress during fiscal 2001

Sep. 3, 2001

Clinical programs at NPS continue steady progression during Q2

Sep. 3, 2001

Study questions cardiovascular safety of COX-2 inhibitors

Sep. 3, 2001

Uriach identifies UR-8880, its lead COX-2 inhibitor as a preclinical candidate

Aug. 31, 2001

Mitsubishi highlights their anti-H. pylori candidate at the ACS meeting

Aug. 31, 2001

Alcon presents potential antiglaucoma 13-oxaprostaglandins at the ACS meeting

Aug. 31, 2001

Neuropeptide Y antagonists designed at Fujisawa

Aug. 31, 2001

Sanofi-Synthelabo discloses PDE5 inhibitors and their use

Aug. 31, 2001

Sumitomo claims compounds useful for neuroretinal degenerative diseases

Aug. 31, 2001

Selective GABA-A alpha5 ligands reported by Merck

Aug. 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...